Vera Therapeutics, Inc.
VERA
$22.57
-$0.04-0.18%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 44.86% | 46.12% | 298.75% | 120.90% | 112.34% |
| Total Receivables | 114.39% | 119.87% | 636.91% | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.16% | 3.42% | -33.63% | -21.14% | -2.72% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 278.55% | 215.14% | -59.19% | -41.26% | -69.34% |
| Total Current Assets | 44.74% | 45.56% | 278.56% | 112.17% | 107.09% |
|
|
|||||
| Total Current Assets | 44.74% | 45.56% | 278.56% | 112.17% | 107.09% |
| Net Property, Plant & Equipment | 73.80% | 58.26% | 42.45% | 22.02% | -48.80% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 672.17% | -75.90% | -72.82% | -70.21% | -1.08% |
| Total Assets | 45.62% | 45.50% | 273.51% | 109.86% | 103.55% |
|
|
|||||
| Total Accounts Payable | 182.10% | 77.81% | -31.06% | -62.59% | -64.88% |
| Total Accrued Expenses | 67.92% | 62.08% | 85.43% | 101.00% | 5.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -59.59% | -47.65% | -39.12% | -25.66% | -17.34% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 82.18% | 50.55% | 13.76% | 7.49% | -31.37% |
|
|
|||||
| Total Current Liabilities | 82.18% | 50.55% | 13.76% | 7.49% | -31.37% |
| Long-Term Debt | 48.15% | 1.68% | 1.62% | 101.54% | 101.36% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 390.77% | 157.45% | 76.92% | 30.89% | -82.30% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -0.35% |
| Total Liabilities | 58.81% | 14.21% | 6.32% | 53.15% | 27.02% |
|
|
|||||
| Common Stock & APIC | 51.14% | 51.52% | 152.84% | 73.33% | 73.14% |
| Retained Earnings | -58.81% | -51.99% | -49.22% | -47.41% | -40.95% |
| Treasury Stock & Other | 217.11% | 478.03% | 56.57% | 1,492.00% | -216.90% |
| Total Common Equity | 42.82% | 51.33% | 467.59% | 133.66% | 133.32% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 42.82% | 51.33% | 467.59% | 133.66% | 133.32% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 42.82% | 51.33% | 467.59% | 133.66% | 133.32% |
|
|
|||||